18.07.2013 • NewsBASFDuPontMonsanto

Peltz’ Trian Has Amassed A “Big Stake” in DuPont

Trian Fund Management, headed by Nelson Peltz, has amassed a "big stake" in chemicals maker DuPont, CNBC said on Wednesday.

Shares of DuPont rose 4.8% on the news of Trian's stake. At the CNBC Institutional Investor Delivering Alpha Conference, Peltz declined to comment in response to questions by CNBC host Andrew Ross Sorkin on his DuPont interest.

DuPont declined to a Reuters request for comment. "We don't comment on market rumors or speculation," DuPont spokesman Michael Hanretta said.

Investors have agitated for months about the company's low stock price compared with rivals Monsanto and BASF. While DuPont is the second-largest seed maker after Monsanto, its stock trades at a large discount to its rival.

DuPont's titanium dioxide paint business, the largest in the world, has been blamed by some investors as weighing on the stock. The business is highly cyclical and requires large infusions of cash to maintain during troughs.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.